Scarica l'app Stockscreener
5.145
0.48%
-0.025
Dopo l'orario di chiusura:
5.15
0.005
+0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FHTX Giù?
Forum
Previsione
Precedente Chiudi:
$5.17
Aprire:
$5.05
Volume 24 ore:
74,883
Relative Volume:
0.60
Capitalizzazione di mercato:
$290.85M
Reddito:
$34.16M
Utile/perdita netta:
$-98.43M
Rapporto P/E:
-2.1987
EPS:
-2.34
Flusso di cassa netto:
$-119.33M
1 W Prestazione:
+3.31%
1M Prestazione:
-12.50%
6M Prestazione:
-16.07%
1 anno Prestazione:
-8.13%
Intervallo 1D:
$5.03
$5.23
Intervallo di 1 settimana:
$4.475
$5.23
Portata 52W:
$2.9448
$10.25
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Nome
Foghorn Therapeutics Inc
Settore
Industria
Telefono
617-586-3100
Indirizzo
500 TECHNOLOGY SQUARE, CAMBRIDGE
Confronta FHTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
5.145 | 292.26M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Iniziato | B. Riley Securities | Buy |
| 2024-09-03 | Iniziato | Jefferies | Buy |
| 2024-08-19 | Iniziato | Evercore ISI | Outperform |
| 2023-03-28 | Iniziato | BofA Securities | Buy |
| 2023-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2021-11-22 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-17 | Iniziato | Cowen | Outperform |
| 2020-11-17 | Iniziato | Goldman | Buy |
| 2020-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-17 | Iniziato | Wedbush | Outperform |
Mostra tutto
Foghorn Therapeutics Inc Borsa (FHTX) Ultime notizie
Does Foghorn Therapeutics Inc. fit your quant trading model2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - Newser
Can technical indicators confirm Foghorn Therapeutics Inc.’s reversalMarket Sentiment Review & Growth Focused Investment Plans - Newser
Foghorn Therapeutics Inc.’s volatility index tracking explainedQuarterly Profit Summary & Expert Verified Movement Alerts - Newser
Statistical indicators supporting Foghorn Therapeutics Inc.’s strengthQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - Newser
Top Risks to Consider Before Buying Foghorn Therapeutics Inc. StockEarnings Overview Report & Technical Pattern Based Signals - Newser
Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update - ADVFN Brasil
Foghorn Therapeutics Inc. stock outlook for YEARWeekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
How sentiment analysis helps forecast Foghorn Therapeutics Inc.2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Foghorn Therapeutics’ SWOT analysis: innovative cancer therapy stock faces pivotal trials - Investing.com Australia
Using flow based indicators on Foghorn Therapeutics Inc.July 2025 Summary & Community Verified Swing Trade Signals - Newser
Is Foghorn Therapeutics Inc. stock ready for a breakout2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Sentiment analysis tools applied to Foghorn Therapeutics Inc.Treasury Yields & AI Powered Trade Plan Recommendations - Newser
How to escape a deep drawdown in Foghorn Therapeutics Inc.Recession Risk & Community Consensus Picks - Newser
Applying Wyckoff theory to Foghorn Therapeutics Inc. stockTrend Confirmation Scanner with Entry Focus - Newser
How Foghorn Therapeutics Inc. stock performs during market volatility - Newser
Leading vs lagging indicators on Foghorn Therapeutics Inc. performanceQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - Newser
Automated trading signals detected on Foghorn Therapeutics Inc.Smart Entry Signals for Active Traders - Newser
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Understanding Foghorn Therapeutics Inc.’s price movementAI Powered Buy Point Forecast Planner - Newser
How cyclical is Foghorn Therapeutics Inc.’s revenue streamFast Growth Mid Cap Picks - sisain.net
Using data filters to optimize entry into Foghorn Therapeutics Inc.Daily Upside Movement Prediction With Data - Newser
Using portfolio simulators with Foghorn Therapeutics Inc. includedGrowth Watchlist for Long Term Positioning - Newser
Comparing Foghorn Therapeutics Inc. in custom built stock radarsShort-Term Swing Opportunity Summary Sheet - Newser
Is Foghorn Therapeutics Inc. meeting your algorithmic filter criteriaAI Model Forecasting Reversal and Breakout Zones - Newser
Research Analysts Offer Predictions for FHTX Q3 Earnings - Defense World
Will Foghorn Therapeutics Inc. bounce back from current supportAI Driven Swing Trade Forecasting Insight - Newser
Real time alert setup for Foghorn Therapeutics Inc. performanceShort-Term Bounce Forecast for Oversold Stocks - Newser
What high frequency data says about Foghorn Therapeutics Inc.Free Entry Alert With Low Drawdown Strategy - Newser
Can volume confirm reversal in Foghorn Therapeutics Inc.Value Holding Return Summary With Outlook - Newser
Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing - Yahoo Finance
Wedbush Research Analysts Boost Earnings Estimates for FHTX - Defense World
Foghorn Therapeutics Inc Azioni (FHTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):